DRE stands for digital rectal exam, a physical test where a urologist inserts a gloved, lubricated finger into the rectum to feel the prostate gland. The word “digital” refers to the finger (digit), not technology. It’s one of the simplest and fastest ways to check the prostate for signs of cancer, enlargement, or infection, and it remains a routine part of urological evaluation despite advances in blood tests and imaging.
What the Exam Actually Checks
The prostate sits directly in front of the rectum, which makes it easy to reach and feel through the rectal wall. During a DRE, the urologist evaluates three things: the size of the gland, the texture of its surface, and whether any lumps or hard spots are present. A normal prostate feels smooth and slightly rubbery, roughly the size of a walnut in younger men.
The back portion of the prostate, called the peripheral zone, is the area most accessible by finger. This matters because the peripheral zone is also where prostate cancer most commonly develops. Beyond the prostate, the exam also lets your provider check the lower rectum and anus for hemorrhoids, fissures, or other abnormalities.
What Different Findings Mean
A urologist can distinguish between several conditions based on what the prostate feels like. A uniformly enlarged but smooth gland typically points to benign prostatic hyperplasia (BPH), the non-cancerous enlargement that’s common in older men. A gland that feels boggy, warm, or tender suggests prostatitis, an infection or inflammation of the prostate.
Cancer has its own distinct characteristics. A cancerous nodule tends to feel hard with a sharp edge and sits level with or below the surface of the gland, rather than rising above it. Infected nodules, by contrast, are usually raised and fade gradually into the surrounding softer tissue. A single hard nodule is more suspicious for cancer than multiple nodules, which are more commonly associated with chronic prostatitis. When the only abnormality is a firm, slightly nodular prostate, about two-thirds of cases turn out to be benign.
How Accurate the DRE Is
As a standalone screening tool, the DRE is far from perfect. Its overall sensitivity for detecting prostate cancer is roughly 60%, meaning it misses about 4 in 10 cancers. Specificity sits around 67%, so about a third of abnormal findings turn out to be something other than cancer. These numbers improve significantly when PSA (prostate-specific antigen) levels are higher. In men with a PSA above 20, the DRE correctly identifies cancer about 80% of the time.
Because of these limitations, the American Urological Association does not recommend DRE as a standalone screening method. Instead, it advises using DRE alongside PSA blood testing for early detection. The two tests complement each other: roughly 2 in 100 men with a normal PSA still harbor an aggressive prostate cancer that produces little or no PSA. In those cases, the DRE may be the only exam that catches something suspicious. An abnormal DRE is considered sufficient grounds for a cancer referral even without a raised PSA level, particularly in men with risk factors like Black ethnicity or a family history of prostate cancer.
When PSA is already elevated, the picture shifts. Current guidance in some systems is to refer directly for further investigation (typically an MRI), since imaging is far more accurate than a finger exam at distinguishing benign causes of elevated PSA from cancer.
What Happens During the Exam
No special preparation is needed. You’ll either lie on your side on the exam table or lean forward over it. The provider first visually inspects the outside of the anus, then applies lubricant to a gloved finger and inserts it into the rectum. The whole process takes less than a minute.
Most people describe the sensation as uncomfortable pressure rather than pain. Taking a slow, deep breath during insertion helps relax the muscles and reduces discomfort. You may feel a brief urge to urinate when the provider presses on the prostate, which is normal.
When a DRE Should Not Be Performed
There are situations where the exam is off the table. It should not be done in people who are significantly immunocompromised, because introducing even a small amount of bacteria could cause a serious infection. Other contraindications include severe anal pain, prolapsed hemorrhoids, anal strictures, and recent anal surgery. Major rectal trauma or an unwilling patient are also clear reasons to skip the exam. In these cases, imaging or other diagnostic methods are used instead.
Why It Still Matters
The DRE is simple, inexpensive, and gives information that no blood test can provide. PSA tells you a number. A DRE tells your urologist what the prostate physically feels like: its shape, symmetry, texture, and whether any area feels distinctly different from the rest. That tactile information helps guide decisions about whether imaging, a biopsy, or watchful monitoring is the right next step. Despite being one of the oldest tools in urology, experts consider it underutilized in modern practice.